Skip to main content

18689pwpadmin

Vivacelle Bio Phase 3 Trial
The Lancet Journal – Efficacy and Safety of Phospholipid Nanoparticles (VBI-S) in Reversing Intractable Hypotension in Patients with Septic Shock Medical Journal

The Lancet Journal – Efficacy and Safety of Phospholipid Nanoparticles (VBI-S) in Reversing Intractable Hypotension in Patients with Septic Shock

A Multicentre, Open-Label, Repeated Measures, Phase 2a Clinical Pilot Trial Background Since the 1990’s attempts to favorably modulate nitric oxide (NO) have been unsuccessful. We hypothesized that because NO is…
18689pwpadmin
January 4, 2024

VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients

https://clinicaltrials.gov/study/NCT04257136?tab=table

Vivacelle Bio named included in 101 top Illinois Biotechnology Companies and Startups – 2021

https://beststartup.us/101-top-illinois-biotechnology-companies-and-startups-of-2021/
World Sepsis Pipeline Insight 2021: Pipeline Product Profiles, Therapeutic Assessment, Pipeline Assessment, Inactive Drugs Assessment, Unmet Needs Press Release

World Sepsis Pipeline Insight 2021: Pipeline Product Profiles, Therapeutic Assessment, Pipeline Assessment, Inactive Drugs Assessment, Unmet Needs

February 09, 2021 09:24 AM Eastern Standard Time DUBLIN--(BUSINESS WIRE)--The "Sepsis Pipeline Insight 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This "Sepsis - Pipeline Insight, 2021," report provides…
18689pwpadmin
February 9, 2021
Vivacelle Bio Receives $5.3 Million Award from the US Navy for a Clinical Trial of VBI-S for Treatment of Hypovolemia of Septic Shock Due to COVID or other Pathogens News

Vivacelle Bio Receives $5.3 Million Award from the US Navy for a Clinical Trial of VBI-S for Treatment of Hypovolemia of Septic Shock Due to COVID or other Pathogens

NEWS PROVIDED BY Vivacelle Bio, Inc. 24 Nov, 2020, 08:00 ET FORT WAYNE, Ind., Nov. 24, 2020 /PRNewswire/ --  Vivacelle Bio, Inc. today announces the Department of Defense awarded $5.3…
18689pwpadmin
November 24, 2020